US

Goji attracts $15 mln

Boston-based Goji, an online personal lines insurance agency, has secured $15 million in funding. Hudson Structured Capital Management Ltd led the round.

Cookie chain Tiff's Treats locks in $25 mln

Austin, Texas-based Tiff’s Treats, a warm cookie chain, has raised $25 million in funding. Morgan Stanley Expansion Capital led the round. In conjunction with the funding, Lincoln Isetta, a managing director at Morgan Stanley Expansion Capital, will join Tiff’s Treats’ board of directors.

Sapphire to raise $100 mln sports tech fund

Sapphire Ventures is raising a $100 million sports tech fund, according to a filing with the SEC.

TechU targets $25 mln for venture fund

TechU Ventures is raising a $25 million first fund, according to a regulatory filing. The firm is managed by Natanel Barookhian, founder of TechU Angels, and based in Great Neck, New York. The filing lists no investors.

Index Ventures leads $21 mln funding in Built

Nashville, Tennessee-based Built, which provides a cloud-based platform to manage the construction lending process, announced it has raised a $21 million Series A round led by Index Ventures. New York-based Nyca Partners also invested in the round. The company has now raised $25 million since it was founded in 2014.

Canal Partners leads funding round for Allbound

Phoenix-based Allbound, a next generation partner relationship management platform, has secured an undisclosed amount of venture funding. Canal Partners led the round with participation from Tallwave Capital and the Arizona Founders Fund. Also, Allbound has named Mike Chadwick as CEO. Current CEO and founder Scott Salkin will remain on the board of directors and serve as chief innovation officer. Salkin's work background includes stints at GoDaddy and Acronis.

Arterys takes in $30 mln Series B

Arterys Inc., a medical imaging company, has secured $30 million in Series B financing. Temasek led the round with participation from Northwell Health Ventures, New York-Presbyterian, Varian Medical Systems, GE Ventures, Fosun, DNA Capital, Emergent Medical Partners and ORI Capital.

Outpost Medicine rakes in $20 mln

Indianapolis and London-based Outpost Medicine, a biopharmaceutical company focused on treating urologic and gastrointestinal disorders, has raised $20 million in funding. The investors included Takeda Ventures, Frazier Healthcare Partners, Novo Holdings A/S, Vivo Capital and Adams Street Partners. Also, the company has appointed Scott Byrd as president and CEO, succeeding David Socks, interim CEO, co-founder of Outpost, and venture partner with Frazier Healthcare Partners. Socks will remain on the board of directors.

European medical device company Xeltis scores $52 mln Series C

Xeltis, a European medical device company, has closed $52 million in Series C financing. The investors included Ysios Capital, Kurma Partners and VI Partners.

Goldman Sachs backs IrisGuard

UK-based IrisGuard, a provider of iris recognition technology payment solutions, has secured an undisclosed amount of funding. The investor was Goldman Sachs' merchant banking division.